Research Blog

Research notes, product guides and peptide handling information from the Southern Labs team.

• Peptide Cold-Chain Integrity: What NZ Researchers Should Confirm Before a Shipment Arrives — A high-purity COA only reflects the moment of testing — not the condition of the compound when it reaches your lab. Here is what cold-chain integrity actually requires, and what to check before a shipment arrives. (2026-09-16)
• What 'Research Grade' Actually Requires on a COA — The term 'research grade' has no regulatory definition in the peptide supply market, which means it means whatever a supplier wants it to mean. Here is what it should require — and how to verify it. (2026-09-13)
• Customs Seizures and NZ Research Timelines: The Real Cost of Ordering Peptides From Overseas — Overseas peptide orders often look cheaper per unit — until you account for seizure risk, re-order delays, and documentation compliance failures. Here is what the landed cost calculation actually looks like for NZ researchers. (2026-09-10)
• How NZ Research Labs Can Cut Lead Times Without Compromising Reagent Quality — International reagent orders expose NZ labs to compounding delays, customs risk, and unpredictable reorder cycles. Here is how domestic stock changes the procurement equation — without trading off on purity documentation. (2026-09-07)
• Retatrutide in New Zealand: Where to Buy Online for Research — A complete NZ researcher's guide to sourcing retatrutide domestically — covering supplier landscape, customs risk, COA verification standards, and why domestic supply matters for your research. (2026-09-03)
• What Laboratory Conditions Actually Require from a Research Compound Supplier — "Laboratory conditions" means more than a clean bench. This guide breaks down what the phrase actually demands from your compound supplier — documentation, analytical verification, and supply chain integrity included. (2026-08-14)
• What Southern Labs Supplies and How It Works — A factual overview of Southern Labs' domestic supply model, independent COA documentation, and product categories for New Zealand laboratory and research purchasers. (2026-08-11)
• NZ Lab Supply for Research Compounds: What Sourcing Origin Actually Changes — Not all lab supply options in New Zealand are built for research compound procurement. Here is how domestic stock, independent COA documentation, and sourcing origin affect what researchers can actually rely on. (2026-08-08)
• How to Evaluate a Research Peptide Supplier in New Zealand — Not all research peptide suppliers are equal on documentation, regulatory positioning, or operational reliability. Here is a structured procurement checklist for New Zealand laboratory buyers. (2026-08-07)
• Sourcing Research Peptides in NZ: Domestic Lab vs. Overseas Vendor — No globally ranked peptide vendor holds domestic NZ stock or offers NZ-specific dispatch. Here is what that gap costs researchers, and what to look for in a local supplier. (2026-08-06)
• Peptides in Research: Market, Quality, and Supply Chain Explained — A data-driven analysis of the global peptide research market, the widening quality gap in research-grade supply, and what New Zealand researchers need to know about sourcing, verification, and Certificates of Analysis. (2026-08-05)
• Peptides for Research: Supply Standards, Purity Documentation, and the NZ Landscape — A research-focused overview of the peptide supply landscape in New Zealand — covering purity documentation standards, the domestic supply advantage, and what the current regulatory environment means for legitimate research operations. (2026-08-04)